Share Price and Basic Stock Data
Last Updated: December 31, 2025, 9:07 pm
| PEG Ratio | 4.06 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BDH Industries Ltd operates in the pharmaceutical sector, reporting a market capitalization of ₹241 Cr and a share price of ₹418. The company has showcased a varied revenue performance over the recent quarters. Sales for the fiscal year ending March 2023 stood at ₹74.46 Cr, a notable increase from ₹69.39 Cr in the previous year. However, the trailing twelve months (TTM) revenue has recorded a slight decline to ₹71.60 Cr. Quarterly sales fluctuated, with the highest quarterly sales of ₹27.11 Cr recorded in March 2024, while the lowest was ₹12.19 Cr in December 2022. The latest quarterly sales for September 2023 were ₹19.35 Cr, indicating a recovery trend post the lower sales in December 2022. The variation in sales figures highlights the company’s responsiveness to market dynamics and operational challenges, typical in the pharmaceutical industry where demand can be influenced by numerous factors, including regulatory changes and competition.
Profitability and Efficiency Metrics
BDH Industries Ltd has demonstrated solid profitability metrics, with a reported net profit of ₹9.75 Cr and a net profit margin of 13.94% for the fiscal year 2025. The operating profit margin (OPM) was recorded at 17.56%, reflecting effective cost management strategies despite the fluctuations in sales. The company’s return on equity (ROE) stood at 14.2%, while the return on capital employed (ROCE) was reported at 17.8%, indicating efficient utilization of equity and capital. The interest coverage ratio (ICR) of 184.18x highlights the company’s strong capacity to cover interest expenses, which is significantly above industry averages, suggesting low financial risk. However, the gross margin can be impacted by rising raw material costs, which is a common challenge in the pharmaceutical sector. Overall, BDH’s financial health shows resilience, with profitability metrics aligning well against sector standards.
Balance Sheet Strength and Financial Ratios
BDH Industries Ltd maintains a strong balance sheet with minimal borrowings of just ₹0.03 Cr, showcasing financial prudence. The reserves have steadily increased to ₹64.86 Cr, providing a solid equity cushion for future investments. The company’s total assets stood at ₹88.93 Cr, with a debt-to-equity ratio of 0.01, indicating a very low reliance on debt financing. This conservative approach to capital structure is favorable, especially in the volatile pharmaceutical industry. The current ratio of 3.95x and quick ratio of 3.51x reflect strong liquidity, ensuring the company can meet its short-term obligations comfortably. Furthermore, the price-to-book value (P/BV) ratio of 2.24x suggests that the stock is reasonably valued in relation to its book value. This financial stability is essential for sustaining operations and facilitating growth in a competitive market.
Shareholding Pattern and Investor Confidence
BDH Industries Ltd’s shareholding structure indicates a balanced distribution of ownership. Promoters hold a substantial 49.70% stake, reflecting strong insider confidence in the company’s prospects. The public holds a 50.04% stake, with the number of shareholders reported at 4,889, indicating a diverse ownership base. Foreign Institutional Investors (FIIs) own a minor 0.28%, suggesting limited foreign interest, which could be both a challenge and an opportunity for the company. The gradual increase in promoter ownership from 49.66% in December 2022 to 49.70% in September 2025 indicates a commitment to the firm’s long-term vision. However, the relatively low FII participation may raise questions regarding broader market confidence. Overall, the stable shareholding pattern suggests a solid foundation for investor confidence, although expanding FII involvement could enhance the stock’s market perception.
Outlook, Risks, and Final Insight
The outlook for BDH Industries Ltd appears cautiously optimistic, with the potential for revenue growth driven by improving operational efficiencies and a strong balance sheet. However, the company faces risks related to fluctuating raw material costs and regulatory challenges that are common in the pharmaceutical sector. The company’s ability to adapt to market conditions will be critical; any significant changes in health regulations or competitive dynamics could impact its profitability. Additionally, while the company’s low debt levels provide a buffer, reliance on domestic market performance poses risks if economic conditions deteriorate. In a scenario where BDH successfully expands its product portfolio and enhances its market presence, it could see substantial growth. Conversely, failure to navigate regulatory landscapes effectively could hinder its operational capabilities, affecting overall performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 129 Cr. | 103 | 231/84.3 | 28.6 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.54 Cr. | 1.85 | 4.29/1.76 | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,816 Cr. | 442 | 479/192 | 99.7 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.3 Cr. | 43.5 | 88.6/37.2 | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 52.4 Cr. | 35.8 | 36.4/17.0 | 125 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 20,197.40 Cr | 1,153.64 | 53.52 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 22.24 | 12.19 | 22.72 | 18.31 | 19.35 | 21.06 | 27.11 | 16.26 | 16.23 | 16.20 | 17.82 | 18.62 | 18.96 |
| Expenses | 18.38 | 9.68 | 20.20 | 16.35 | 16.18 | 17.57 | 23.30 | 14.30 | 13.18 | 12.67 | 14.75 | 16.50 | 15.63 |
| Operating Profit | 3.86 | 2.51 | 2.52 | 1.96 | 3.17 | 3.49 | 3.81 | 1.96 | 3.05 | 3.53 | 3.07 | 2.12 | 3.33 |
| OPM % | 17.36% | 20.59% | 11.09% | 10.70% | 16.38% | 16.57% | 14.05% | 12.05% | 18.79% | 21.79% | 17.23% | 11.39% | 17.56% |
| Other Income | 0.19 | 0.13 | 0.34 | 0.37 | 0.41 | 0.37 | 0.43 | 0.38 | 0.43 | 0.46 | 0.57 | 0.55 | 0.55 |
| Interest | 0.02 | 0.04 | 0.07 | 0.04 | 0.03 | 0.02 | 0.10 | 0.02 | 0.04 | 0.01 | 0.01 | 0.01 | 0.03 |
| Depreciation | 0.15 | 0.15 | 0.13 | 0.13 | 0.13 | 0.13 | 0.18 | 0.22 | 0.23 | 0.23 | 0.23 | 0.22 | 0.22 |
| Profit before tax | 3.88 | 2.45 | 2.66 | 2.16 | 3.42 | 3.71 | 3.96 | 2.10 | 3.21 | 3.75 | 3.40 | 2.44 | 3.63 |
| Tax % | 25.00% | 25.31% | 28.20% | 25.00% | 26.61% | 25.07% | 25.25% | 25.24% | 25.23% | 25.07% | 26.76% | 25.00% | 27.82% |
| Net Profit | 2.91 | 1.84 | 1.91 | 1.62 | 2.51 | 2.78 | 2.96 | 1.57 | 2.41 | 2.81 | 2.49 | 1.83 | 2.62 |
| EPS in Rs | 5.05 | 3.20 | 3.32 | 2.81 | 4.36 | 4.83 | 5.14 | 2.73 | 4.19 | 4.88 | 4.32 | 3.18 | 4.55 |
Last Updated: December 27, 2025, 9:06 pm
Below is a detailed analysis of the quarterly data for BDH Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 18.96 Cr.. The value appears strong and on an upward trend. It has increased from 18.62 Cr. (Jun 2025) to 18.96 Cr., marking an increase of 0.34 Cr..
- For Expenses, as of Sep 2025, the value is 15.63 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.50 Cr. (Jun 2025) to 15.63 Cr., marking a decrease of 0.87 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.33 Cr.. The value appears strong and on an upward trend. It has increased from 2.12 Cr. (Jun 2025) to 3.33 Cr., marking an increase of 1.21 Cr..
- For OPM %, as of Sep 2025, the value is 17.56%. The value appears strong and on an upward trend. It has increased from 11.39% (Jun 2025) to 17.56%, marking an increase of 6.17%.
- For Other Income, as of Sep 2025, the value is 0.55 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.55 Cr..
- For Interest, as of Sep 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Jun 2025) to 0.03 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Sep 2025, the value is 0.22 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.22 Cr..
- For Profit before tax, as of Sep 2025, the value is 3.63 Cr.. The value appears strong and on an upward trend. It has increased from 2.44 Cr. (Jun 2025) to 3.63 Cr., marking an increase of 1.19 Cr..
- For Tax %, as of Sep 2025, the value is 27.82%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Jun 2025) to 27.82%, marking an increase of 2.82%.
- For Net Profit, as of Sep 2025, the value is 2.62 Cr.. The value appears strong and on an upward trend. It has increased from 1.83 Cr. (Jun 2025) to 2.62 Cr., marking an increase of 0.79 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.55. The value appears strong and on an upward trend. It has increased from 3.18 (Jun 2025) to 4.55, marking an increase of 1.37.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:06 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42.38 | 44.27 | 45.84 | 43.18 | 40.94 | 51.69 | 59.48 | 57.45 | 69.39 | 74.46 | 85.83 | 66.51 | 71.60 |
| Expenses | 38.71 | 40.47 | 41.77 | 38.37 | 35.58 | 44.69 | 50.51 | 48.94 | 60.30 | 63.50 | 73.40 | 54.91 | 59.55 |
| Operating Profit | 3.67 | 3.80 | 4.07 | 4.81 | 5.36 | 7.00 | 8.97 | 8.51 | 9.09 | 10.96 | 12.43 | 11.60 | 12.05 |
| OPM % | 8.66% | 8.58% | 8.88% | 11.14% | 13.09% | 13.54% | 15.08% | 14.81% | 13.10% | 14.72% | 14.48% | 17.44% | 16.83% |
| Other Income | 1.23 | 1.22 | 1.80 | 1.24 | 0.82 | 0.89 | 0.80 | 1.30 | 1.33 | 0.84 | 1.58 | 1.84 | 2.13 |
| Interest | 0.74 | 0.48 | 0.33 | 0.35 | 0.25 | 0.52 | 0.69 | 0.28 | 0.23 | 0.16 | 0.18 | 0.07 | 0.06 |
| Depreciation | 0.76 | 0.74 | 0.73 | 0.72 | 0.75 | 0.83 | 0.96 | 0.79 | 0.63 | 0.57 | 0.57 | 0.91 | 0.90 |
| Profit before tax | 3.40 | 3.80 | 4.81 | 4.98 | 5.18 | 6.54 | 8.12 | 8.74 | 9.56 | 11.07 | 13.26 | 12.46 | 13.22 |
| Tax % | 32.65% | 32.11% | 33.06% | 33.13% | 27.22% | 26.30% | 26.72% | 27.35% | 24.37% | 25.84% | 25.49% | 25.60% | |
| Net Profit | 2.30 | 2.57 | 3.23 | 3.34 | 3.76 | 4.83 | 5.94 | 6.36 | 7.22 | 8.20 | 9.87 | 9.27 | 9.75 |
| EPS in Rs | 3.99 | 4.46 | 5.61 | 5.80 | 6.53 | 8.39 | 10.32 | 11.05 | 12.54 | 14.24 | 17.14 | 16.10 | 16.93 |
| Dividend Payout % | 30.99% | 39.29% | 36.78% | 35.57% | 35.55% | 33.82% | 25.00% | 28.02% | 28.72% | 28.10% | 26.26% | 27.96% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 11.74% | 25.68% | 3.41% | 12.57% | 28.46% | 22.98% | 7.07% | 13.52% | 13.57% | 20.37% | -6.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 13.94% | -22.28% | 9.17% | 15.88% | -5.48% | -15.91% | 6.45% | 0.05% | 6.79% | -26.44% |
BDH Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -1% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 32% |
| 3 Years: | 35% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:30 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 | 5.94 | 5.76 | 5.76 | 5.76 | 5.76 | 5.76 |
| Reserves | 17.18 | 18.14 | 21.36 | 23.29 | 25.32 | 28.40 | 32.30 | 37.13 | 42.83 | 48.94 | 56.40 | 63.00 | 64.86 |
| Borrowings | 11.33 | 8.88 | 9.47 | 8.43 | 7.53 | 12.99 | 9.22 | 8.51 | 2.25 | 4.85 | 8.69 | 0.98 | 0.03 |
| Other Liabilities | 13.75 | 18.61 | 15.28 | 16.72 | 18.10 | 18.42 | 17.68 | 19.31 | 18.07 | 20.48 | 22.57 | 17.20 | 18.28 |
| Total Liabilities | 48.20 | 51.57 | 52.05 | 54.38 | 56.89 | 65.75 | 65.14 | 70.89 | 68.91 | 80.03 | 93.42 | 86.94 | 88.93 |
| Fixed Assets | 14.69 | 13.22 | 13.10 | 22.94 | 22.59 | 22.02 | 21.10 | 20.31 | 19.61 | 19.03 | 20.35 | 19.66 | 19.23 |
| CWIP | 0.06 | 0.00 | 4.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 0.35 | 0.35 | 0.35 |
| Other Assets | 33.45 | 38.35 | 34.90 | 31.44 | 34.30 | 43.73 | 44.04 | 50.58 | 49.30 | 60.65 | 72.72 | 66.93 | 69.35 |
| Total Assets | 48.20 | 51.57 | 52.05 | 54.38 | 56.89 | 65.75 | 65.14 | 70.89 | 68.91 | 80.03 | 93.42 | 86.94 | 88.93 |
Below is a detailed analysis of the balance sheet data for BDH Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 5.76 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.76 Cr..
- For Reserves, as of Sep 2025, the value is 64.86 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Mar 2025) to 64.86 Cr., marking an increase of 1.86 Cr..
- For Borrowings, as of Sep 2025, the value is 0.03 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.98 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.95 Cr..
- For Other Liabilities, as of Sep 2025, the value is 18.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.20 Cr. (Mar 2025) to 18.28 Cr., marking an increase of 1.08 Cr..
- For Total Liabilities, as of Sep 2025, the value is 88.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.94 Cr. (Mar 2025) to 88.93 Cr., marking an increase of 1.99 Cr..
- For Fixed Assets, as of Sep 2025, the value is 19.23 Cr.. The value appears to be declining and may need further review. It has decreased from 19.66 Cr. (Mar 2025) to 19.23 Cr., marking a decrease of 0.43 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.35 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.35 Cr..
- For Other Assets, as of Sep 2025, the value is 69.35 Cr.. The value appears strong and on an upward trend. It has increased from 66.93 Cr. (Mar 2025) to 69.35 Cr., marking an increase of 2.42 Cr..
- For Total Assets, as of Sep 2025, the value is 88.93 Cr.. The value appears strong and on an upward trend. It has increased from 86.94 Cr. (Mar 2025) to 88.93 Cr., marking an increase of 1.99 Cr..
Notably, the Reserves (64.86 Cr.) exceed the Borrowings (0.03 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -7.66 | -5.08 | -5.40 | -3.62 | -2.17 | -5.99 | -0.25 | 0.00 | 6.84 | 6.11 | 3.74 | 10.62 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68.04 | 80.88 | 63.78 | 67.37 | 63.48 | 88.97 | 67.62 | 96.44 | 76.38 | 81.57 | 120.60 | 77.82 |
| Inventory Days | 65.19 | 70.93 | 61.18 | 39.41 | 95.20 | 88.97 | 50.59 | 53.31 | 50.00 | 52.59 | 30.28 | 65.17 |
| Days Payable | 143.99 | 201.25 | 162.04 | 191.94 | 244.14 | 188.21 | 157.61 | 171.21 | 122.59 | 138.98 | 127.90 | 133.60 |
| Cash Conversion Cycle | -10.76 | -49.44 | -37.08 | -85.16 | -85.47 | -10.27 | -39.40 | -21.46 | 3.79 | -4.81 | 22.98 | 9.39 |
| Working Capital Days | -74.07 | -75.69 | -71.58 | -90.45 | -60.36 | -29.16 | -31.36 | 6.16 | 56.23 | 48.58 | 71.32 | 102.40 |
| ROCE % | 12.96% | 12.67% | 14.69% | 14.32% | 14.21% | 16.40% | 18.59% | 18.21% | 18.24% | 20.35% | 20.61% | 17.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 16.11 | 17.14 | 14.25 | 12.55 | 11.05 |
| Diluted EPS (Rs.) | 16.11 | 17.14 | 14.25 | 12.55 | 11.05 |
| Cash EPS (Rs.) | 17.68 | 18.14 | 15.24 | 13.64 | 12.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 117.14 | 105.67 | 92.70 | 82.07 | 70.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.43 | 107.96 | 95.00 | 84.39 | 72.51 |
| Dividend / Share (Rs.) | 4.50 | 4.50 | 4.00 | 3.60 | 3.00 |
| Revenue From Operations / Share (Rs.) | 115.52 | 149.08 | 129.33 | 120.53 | 96.73 |
| PBDIT / Share (Rs.) | 23.35 | 24.33 | 20.48 | 17.30 | 16.53 |
| PBIT / Share (Rs.) | 21.78 | 23.33 | 19.50 | 16.20 | 15.20 |
| PBT / Share (Rs.) | 21.65 | 23.02 | 19.22 | 16.59 | 14.72 |
| Net Profit / Share (Rs.) | 16.11 | 17.14 | 14.25 | 12.55 | 10.71 |
| PBDIT Margin (%) | 20.21 | 16.32 | 15.84 | 14.35 | 17.08 |
| PBIT Margin (%) | 18.85 | 15.65 | 15.07 | 13.44 | 15.71 |
| PBT Margin (%) | 18.74 | 15.43 | 14.86 | 13.76 | 15.22 |
| Net Profit Margin (%) | 13.94 | 11.49 | 11.01 | 10.40 | 11.06 |
| Return on Networth / Equity (%) | 13.75 | 16.22 | 15.37 | 15.28 | 15.24 |
| Return on Capital Employeed (%) | 17.90 | 21.40 | 20.25 | 18.91 | 20.54 |
| Return On Assets (%) | 10.66 | 10.56 | 10.25 | 10.48 | 8.97 |
| Total Debt / Equity (X) | 0.01 | 0.14 | 0.09 | 0.04 | 0.20 |
| Asset Turnover Ratio (%) | 0.73 | 0.98 | 0.99 | 0.99 | 0.84 |
| Current Ratio (X) | 3.95 | 2.37 | 2.46 | 2.51 | 1.88 |
| Quick Ratio (X) | 3.51 | 2.20 | 2.17 | 2.16 | 1.67 |
| Inventory Turnover Ratio (X) | 10.74 | 9.81 | 6.89 | 8.16 | 7.35 |
| Dividend Payout Ratio (NP) (%) | 27.93 | 23.33 | 25.26 | 23.91 | 22.63 |
| Dividend Payout Ratio (CP) (%) | 25.45 | 22.05 | 23.62 | 21.98 | 20.13 |
| Earning Retention Ratio (%) | 72.07 | 76.67 | 74.74 | 76.09 | 77.37 |
| Cash Earning Retention Ratio (%) | 74.55 | 77.95 | 76.38 | 78.02 | 79.87 |
| Interest Coverage Ratio (X) | 184.18 | 77.26 | 74.69 | 44.22 | 34.81 |
| Interest Coverage Ratio (Post Tax) (X) | 128.03 | 55.43 | 52.96 | 31.06 | 23.55 |
| Enterprise Value (Cr.) | 121.21 | 145.85 | 43.83 | 60.41 | 40.73 |
| EV / Net Operating Revenue (X) | 1.82 | 1.70 | 0.58 | 0.87 | 0.70 |
| EV / EBITDA (X) | 9.02 | 10.41 | 3.72 | 6.06 | 4.15 |
| MarketCap / Net Operating Revenue (X) | 2.28 | 1.89 | 0.87 | 1.11 | 0.95 |
| Retention Ratios (%) | 72.06 | 76.66 | 74.73 | 76.08 | 77.36 |
| Price / BV (X) | 2.24 | 2.67 | 1.22 | 1.63 | 1.31 |
| Price / Net Operating Revenue (X) | 2.28 | 1.89 | 0.87 | 1.11 | 0.95 |
| EarningsYield | 0.06 | 0.06 | 0.12 | 0.09 | 0.11 |
After reviewing the key financial ratios for BDH Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 16.11. This value is within the healthy range. It has decreased from 17.14 (Mar 24) to 16.11, marking a decrease of 1.03.
- For Diluted EPS (Rs.), as of Mar 25, the value is 16.11. This value is within the healthy range. It has decreased from 17.14 (Mar 24) to 16.11, marking a decrease of 1.03.
- For Cash EPS (Rs.), as of Mar 25, the value is 17.68. This value is within the healthy range. It has decreased from 18.14 (Mar 24) to 17.68, marking a decrease of 0.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 117.14. It has increased from 105.67 (Mar 24) to 117.14, marking an increase of 11.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.43. It has increased from 107.96 (Mar 24) to 119.43, marking an increase of 11.47.
- For Dividend / Share (Rs.), as of Mar 25, the value is 4.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 4.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 115.52. It has decreased from 149.08 (Mar 24) to 115.52, marking a decrease of 33.56.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.35. This value is within the healthy range. It has decreased from 24.33 (Mar 24) to 23.35, marking a decrease of 0.98.
- For PBIT / Share (Rs.), as of Mar 25, the value is 21.78. This value is within the healthy range. It has decreased from 23.33 (Mar 24) to 21.78, marking a decrease of 1.55.
- For PBT / Share (Rs.), as of Mar 25, the value is 21.65. This value is within the healthy range. It has decreased from 23.02 (Mar 24) to 21.65, marking a decrease of 1.37.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 16.11. This value is within the healthy range. It has decreased from 17.14 (Mar 24) to 16.11, marking a decrease of 1.03.
- For PBDIT Margin (%), as of Mar 25, the value is 20.21. This value is within the healthy range. It has increased from 16.32 (Mar 24) to 20.21, marking an increase of 3.89.
- For PBIT Margin (%), as of Mar 25, the value is 18.85. This value is within the healthy range. It has increased from 15.65 (Mar 24) to 18.85, marking an increase of 3.20.
- For PBT Margin (%), as of Mar 25, the value is 18.74. This value is within the healthy range. It has increased from 15.43 (Mar 24) to 18.74, marking an increase of 3.31.
- For Net Profit Margin (%), as of Mar 25, the value is 13.94. This value exceeds the healthy maximum of 10. It has increased from 11.49 (Mar 24) to 13.94, marking an increase of 2.45.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.75. This value is below the healthy minimum of 15. It has decreased from 16.22 (Mar 24) to 13.75, marking a decrease of 2.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.90. This value is within the healthy range. It has decreased from 21.40 (Mar 24) to 17.90, marking a decrease of 3.50.
- For Return On Assets (%), as of Mar 25, the value is 10.66. This value is within the healthy range. It has increased from 10.56 (Mar 24) to 10.66, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.14 (Mar 24) to 0.01, marking a decrease of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has decreased from 0.98 (Mar 24) to 0.73, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 3.95. This value exceeds the healthy maximum of 3. It has increased from 2.37 (Mar 24) to 3.95, marking an increase of 1.58.
- For Quick Ratio (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 2. It has increased from 2.20 (Mar 24) to 3.51, marking an increase of 1.31.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.74. This value exceeds the healthy maximum of 8. It has increased from 9.81 (Mar 24) to 10.74, marking an increase of 0.93.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 27.93. This value is within the healthy range. It has increased from 23.33 (Mar 24) to 27.93, marking an increase of 4.60.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 25.45. This value is within the healthy range. It has increased from 22.05 (Mar 24) to 25.45, marking an increase of 3.40.
- For Earning Retention Ratio (%), as of Mar 25, the value is 72.07. This value exceeds the healthy maximum of 70. It has decreased from 76.67 (Mar 24) to 72.07, marking a decrease of 4.60.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 74.55. This value exceeds the healthy maximum of 70. It has decreased from 77.95 (Mar 24) to 74.55, marking a decrease of 3.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 184.18. This value is within the healthy range. It has increased from 77.26 (Mar 24) to 184.18, marking an increase of 106.92.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 128.03. This value is within the healthy range. It has increased from 55.43 (Mar 24) to 128.03, marking an increase of 72.60.
- For Enterprise Value (Cr.), as of Mar 25, the value is 121.21. It has decreased from 145.85 (Mar 24) to 121.21, marking a decrease of 24.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.82. This value is within the healthy range. It has increased from 1.70 (Mar 24) to 1.82, marking an increase of 0.12.
- For EV / EBITDA (X), as of Mar 25, the value is 9.02. This value is within the healthy range. It has decreased from 10.41 (Mar 24) to 9.02, marking a decrease of 1.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.28, marking an increase of 0.39.
- For Retention Ratios (%), as of Mar 25, the value is 72.06. This value exceeds the healthy maximum of 70. It has decreased from 76.66 (Mar 24) to 72.06, marking a decrease of 4.60.
- For Price / BV (X), as of Mar 25, the value is 2.24. This value is within the healthy range. It has decreased from 2.67 (Mar 24) to 2.24, marking a decrease of 0.43.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.28. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.28, marking an increase of 0.39.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BDH Industries Ltd:
- Net Profit Margin: 13.94%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.9% (Industry Average ROCE: 16.29%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.75% (Industry Average ROE: 15.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 128.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.51
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.1 (Industry average Stock P/E: 53.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.94%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | Nair Baug, Akurli Road, Mumbai Maharashtra 400101 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Jayashree Nair | Chairperson & Managing Director |
| Mr. S C Kachhara | Joint Managing Director & CFO |
| Ms. Karthika Nair | Non Executive Director |
| Mr. Prabhakar Dalal | Independent Director |
| Dr. Mitul Patel | Independent Director |
| Mr. Suresh Chandra Kookada | Independent Director |
FAQ
What is the intrinsic value of BDH Industries Ltd?
BDH Industries Ltd's intrinsic value (as of 01 January 2026) is ₹354.43 which is 16.60% lower the current market price of ₹425.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹245 Cr. market cap, FY2025-2026 high/low of ₹524/241, reserves of ₹64.86 Cr, and liabilities of ₹88.93 Cr.
What is the Market Cap of BDH Industries Ltd?
The Market Cap of BDH Industries Ltd is 245 Cr..
What is the current Stock Price of BDH Industries Ltd as on 01 January 2026?
The current stock price of BDH Industries Ltd as on 01 January 2026 is ₹425.
What is the High / Low of BDH Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BDH Industries Ltd stocks is ₹524/241.
What is the Stock P/E of BDH Industries Ltd?
The Stock P/E of BDH Industries Ltd is 25.1.
What is the Book Value of BDH Industries Ltd?
The Book Value of BDH Industries Ltd is 123.
What is the Dividend Yield of BDH Industries Ltd?
The Dividend Yield of BDH Industries Ltd is 1.06 %.
What is the ROCE of BDH Industries Ltd?
The ROCE of BDH Industries Ltd is 17.8 %.
What is the ROE of BDH Industries Ltd?
The ROE of BDH Industries Ltd is 14.2 %.
What is the Face Value of BDH Industries Ltd?
The Face Value of BDH Industries Ltd is 10.0.